HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boroojerdi, B. Articles by Hallett, M. Search for Related Content PubMed PubMed Citation Articles by Boroojerdi, B. Articles by Hallett, M. Related Collections Dystonia Botulinum toxin TMS

Effects of botulinum toxin on motor system excitability in patients with writer’s cramp

From the Neurologische Klinik (Dr. Boroojerdi), Universitätsklinikum, Aachen, Germany; and Human Cortical Physiology (Drs. Boroojerdi and Cohen) and Human Motor Control (Dr. Hallett) Sections, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD.

Address correspondence and reprint requests to Dr. B. Boroojerdi, Neurologische Klinik, Universtätsklinikum, Pauwelsstr. 30, 52074 Aachen, Germany; e-mail: bboroojerdi{at}ukaachen.de

Objective: To investigate botulinum toxin (BTX) effects on central and peripheral motor excitability in writer’s cramp.

Methods: Using transcranial magnetic stimulation over the motor cortex and brainstem and peripheral electrical stimulation, the authors investigated measures of motor cortical and peripheral motor excitability on the affected and unaffected side before and 2 to 4 weeks after BTX A injection into the affected muscles in six patients with writer’s cramp. The following motor excitability measures were studied: resting and active motor threshold, cortical silent period, intracortical inhibition and facilitation using the double-pulse technique, recruitment curves, motor evoked potentials following magnetic brainstem stimulation, and maximum M-response amplitude following supramaximal peripheral nerve stimulation.

Results: BTX injection improved function and reduced the M response. No other measures of motor system excitability showed significant changes following BTX injection, and there was no difference in these measures between sides.

Conclusions: BTX A effects on motor system excitability seem to be based mainly on its peripheral mechanisms of action. There was no difference in the motor system excitability between the clinically affected and unaffected sides in this group of patients.

Received May 6, 2003. Accepted in final form August 4, 2003.

This article has been cited by other articles:

				C. Dresel, B. Haslinger, F. Castrop, A. M. Wohlschlaeger, and A. O. Ceballos-Baumann Silent event-related fMRI reveals deficient motor and enhanced somatosensory activation in orofacial dystonia Brain, January 1, 2006; 129(1): 36 - 46. [Abstract] [Full Text] [PDF]